Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease

scientific article published on 07 January 2019

Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S11095-018-2556-5
P698PubMed publication ID30617777

P50authorAshim K MitraQ87995094
Dhananjay PalQ96247254
P2093author name stringAshim K Mitra
Abayomi Ogundele
Vrinda Gote
P433issue2
P921main subjectpharmacokineticsQ323936
cyclosporineQ367700
eye diseaseQ3041498
P304page(s)36
P577publication date2019-01-07
P1433published inPharmaceutical ResearchQ7180737
P1476titleOcular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease
P478volume36

Reverse relations

cites work (P2860)
Q89993054Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents
Q90309286Assembling Surfactants-Mucoadhesive Polymer Nanomicelles (ASMP-Nano) for Ocular Delivery of Cyclosporine-A
Q91905513Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
Q91632324Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease

Search more.